Sign in Create account Request Demo

States / Missouri / HB 1524

HB 1524 Reported from Committee

Allows pharmaceutical companies to communicate off-label treatment uses to health care professionals

Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Overview Bill text 2 Compare versions History 12 Sponsors
Apr 26, 2018
Reported Do Pass (H) - AYES: 8 NOES: 0 PRESENT: 0
Apr 25, 2018
Executive Session Completed (H)
Apr 25, 2018
Voted Do Pass (H)
Apr 17, 2018
HCS Reported Do Pass (H) - AYES: 9 NOES: 0 PRESENT: 0
Apr 17, 2018
Referred: Rules - Administrative Oversight(H)
Apr 11, 2018
Executive Session Completed (H)
Apr 11, 2018
HCS Voted Do Pass (H)
Apr 4, 2018
Public Hearing Completed (H)
Jan 24, 2018
Referred: Health and Mental Health Policy(H)
Jan 4, 2018
Read Second Time (H)
Jan 3, 2018
Read First Time (H)
Dec 6, 2017
Prefiled (H)